“Inflammatory Leiomyosarcoma” and “Histiocyte-rich Rhabdomyoblastic Tumor”: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as “Inflammatory Rhabdomyoblastic Tumor”

Jeffrey M. Cloutier, Gregory W. Charville, Fredrik Mertens, William R. Sukov, Karen Fritchie, Kyle Perry, Mark Edgar, Ross Rowsey, Andrew L. Folpe